BOBBY W. SANDAGE, JR., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Fortress Biotech, Inc.

Filing Date Source Excerpt
2012-07-13 "Dr. Sandage has over 30 years of experience in the pharmaceutical industry... Dr. Sandage has a B.S. in pharmacy from the University of Arkansas and a Ph.D. in clinical pharmacy from Purdue University."

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2017-04-26 Dr. Sandage was appointed as a member of our Board of Directors on October 25, 2016. He serves on the Audit Committee, Compensation Committee, and Nominating and Governance Committee. Director compensation table shows $58,868 total compensation.
2018-05-07 The Audit Committee consists of Dr. Sandage (Chairman), Dr. Pedder and Mr. Reynolds. The Compensation Committee consists of Dr. Pedder (Chairperson), Mr. Reynolds and Dr. Sandage. The Nominating and Governance Committee consists of Mr. Reynolds (Chairman), Dr. Pedder and Dr. Sandage. Director compensation table shows Bobby W. Sandage, Jr., Ph.D. received $80,317 in 2017.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-13